July 14, 2008 -- Olympic swimmer Eric Shanteau, 24, says he has testicular cancer and is delaying his testicular cancer surgery until after he's done competing in Beijing.
According to media reports, Shanteau noticed a testicular abnormality but didn't see a doctor until his girlfriend urged him to do so. Shanteau got the testicular cancer diagnosis a week before the Olympic trials. Shanteau's doctors recommended surgery as soon as possible but saw no signs that the cancer had spread.
After weighing his options and risks -- and his life's work to get to the Olympics -- Shanteau decided to delay treatment until after the Olympics. He'll be closely monitored during the games and will drop out if there is any sign his cancer is spreading.
Taking a Risk?
Shanteau's testicular cancer is in its early stages and can be closely monitored by blood tests and CT scans, and that makes his case unique, says Stephen Williams, MD, professor of medicine at Indiana University School of Medicine and director of the Indiana University Melvin and Bren Simon Cancer Center, where cyclist Lance Armstrong was treated for testicular cancer. Williams isn't treating Shanteau.
"He could be treated before things get out of hand," Williams tells WebMD. "In his particular case, I actually think that the decision that he made -- given the circumstances -- is acceptable. I would not ever want to be quoted as saying there's no hurry in getting testicular cancer treated, because nothing could be farther from the truth."
Not all doctors are comfortable with Shanteau's decision to delay his testicular cancer surgery.
"If he hasn't had his testicle removed ... it would be just stupid. Just have it removed ... because there's a chance of it spreading over the next month," urologist Ronald Hrebinko, MD, of the University of Pittsburgh Medical Center, tells WebMD.
The surgery is "not a big operation; it doesn't involve muscle cutting or anything like that," explains Hrebinko, who isn't one of Shanteau's doctors. Shanteau would likely only need a few days off from the surgery, Hrebinko says.
Of the 8,000 new cases per year in the U.S., 80% to 90% occur in men younger than 35, according to Otis Brawley, MD, chief medical officer of the American Cancer Society.